
|Articles|October 6, 2003
Extended-cycle OC offers more convenience
Clinicians can soon offer women the convenience of an extended-cycle oral contraceptive (OC). The FDA recently approved levonorgestrel/ethinyl estradiol (Seasonale, Barr Laboratories) 0.15 mg/0.03 mg tablets for the prevention of pregnancy. The manufacturer plans a November 1 launch for Seasonale, the first extended-cycle OC to receive FDA approval.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
2
Delgocitinib Improves Patients’ Chronic Hand Eczema
3
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
4
What TrumpRx Means for Independent Pharmacies and Their Patients
5




























































































































